3 withdrawn. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Keratoconus: new trials by email Literature Review of Keratoconus trials Research Report on Keratoconus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PXL-Platinum 330 in Eyes With Corneal Thinning Conditions Pulsed or continuous lighting - Corneal Thinning, Keratoconus | Phase 1 / Phase 2 | Withdrawn | Vishal Jhanji | 2023-08-15 | 2023-10-05 | |
| The Role of Antioxidant Supplementation in Keratoconus Patients Antioxidants (Vitamins A,C,E) plus GSH, Placebo, Centrum - Keratoconus | Phase 2 | Withdrawn | University of Miami | 2021-08-01 | 2021-08-16 | |
| Corneal Crosslinking in Keratoconus and Corneal Ectasia Riboflavin, Placebo - Progressive Keratoconus, Corneal Ectasia | Phase 2 / Phase 3 | Withdrawn | Ohio State University | 2008-04-01 | 2017-04-20 |
Corneal Diseases (1) · Dilatation, Pathologic (1)
Eye Diseases (3) · Corneal Diseases (2) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Antioxidants (1) · Heart Rate (1) · Riboflavin (1)
Ohio State University (1) · University of Miami (1) · Vishal Jhanji (1)
United States (3)
Ellen Koo, M.D. (1) · Richard Keates, MD (1) · Vishal Jhanji, MD (1)